Showing results (1831-1840 of 1,918) with videos related to
Sort By:
Pageof 192
AIDS Research and Therapy|July 11, 2025
Risk of uveitis in patients with human immunodeficiency virus: a cohort study through TriNetX databaseBing-Qi Wu, Hou-Ting Kuo, Alan Y Hsu, et al.JAMA Ophthalmology|March 27, 2025
Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy Risk Among Patients With DiabetesAlan Y Hsu, Hou-Ting Kuo, Yu-Hsun Wang, et al.Journal of the Academy of Nutrition and Dietetics|March 9, 2020
Neighborhood Food Outlet Access and Dietary Intake among Adults with Chronic Kidney Disease: Results from the Chronic Renal Insufficiency Cohort StudyJessica M Madrigal, Esteban Cedillo-Couvert, Ana C Ricardo, et al.BMC Nephrology|February 22, 2019
Insulin resistance and chronic kidney disease progression, cardiovascular events, and death: findings from the chronic renal insufficiency cohort studySarah J Schrauben, Christopher Jepson, Jesse Y Hsu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2018
Phase II Study of Taselisib (GDC-0032) in Combination with Fulvestrant in Patients with HER2-Negative, Hormone Receptor-Positive Advanced Breast CancerMaura N Dickler, Cristina Saura, Donald A Richards, et al.Kidney International Reports|June 25, 2021
Hospitalization Trajectories and Risks of ESKD and Death in Individuals With CKDAnand Srivastava, Xuan Cai, Rupal Mehta, et al.Cell Reports|February 2, 2022
SIX1 reprograms myogenic transcription factors to maintain the rhabdomyosarcoma undifferentiated stateJessica Y Hsu, Etienne P Danis, Stephanie Nance, et al.ERJ Open Research|December 3, 2025
Home sputum collection for Aspergillus fumigatus detection in adults with cystic fibrosisGina Hong, Joanna Walsh, Allen Koshy, et al.Cell Reports|February 27, 2024
Flvcr1a deficiency promotes heme-based energy metabolism dysfunction in skeletal muscleMiriam Mistretta, Veronica Fiorito, Anna Lucia Allocco, et al.Kidney International|November 27, 2018
Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trialDavid M Charytan, Jonathan Himmelfarb, T Alp Ikizler, et al.Pageof 192